雄激素剥夺-话题@MedSci

#雄激素剥夺#

23篇内容 | 1258人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2181207, encodeId=44ac218120eef, content=<a href='/topic/show?id=98773329350' target=_blank style='color:#2F92EE;'>#动脉粥样硬化#</a> <a href='/topic/show?id=6b4c98688cb' target=_blank style='color:#2F92EE;'>#雄激素剥夺#</a>, objectTitle=ATVB 北京大学徐涛/姚伟娟团队揭示雄激素剥夺治疗相关动脉粥样硬化进展的机制, objectType=article, longId=809088, objectId=fdef809088e2, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20221109/1668017232524_4754896.png, objectUrl=/article/show_article.do?id=fdef809088e2, replyNumber=0, likeNumber=76, createdTime=2024-01-13, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=陕西省, moduleDTOList=[ModuleDTO(moduleId=fdef809088e2, moduleTitle=ATVB 北京大学徐涛/姚伟娟团队揭示雄激素剥夺治疗相关动脉粥样硬化进展的机制, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fdef809088e2)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=1818962, encodeId=9800181896249, content=<a href='/topic/show?id=6b4c98688cb' target=_blank style='color:#2F92EE;'>#雄激素剥夺#</a>, objectTitle=Eur Urol Oncol：雄激素剥夺疗法联合根治性局部治疗与单独的雄激素剥夺疗法治疗新诊断寡转移性前列腺癌的疗效比较 , objectType=article, longId=732585, objectId=c18be325856d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c18be325856d, replyNumber=0, likeNumber=0, createdTime=2022-12-12, rootId=0, userName=zhaozhouchifen, userId=524d95, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c18be325856d, moduleTitle=Eur Urol Oncol：雄激素剥夺疗法联合根治性局部治疗与单独的雄激素剥夺疗法治疗新诊断寡转移性前列腺癌的疗效比较 , moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c18be325856d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1818960, encodeId=19c51818960e9, content=<a href='/topic/show?id=6b4c98688cb' target=_blank style='color:#2F92EE;'>#雄激素剥夺#</a>, objectTitle=Int J Urol：临床T3b前列腺癌患者中，根治性前列腺切除术与体外放射治疗+雄激素剥夺治疗哪个好？, objectType=article, longId=301213, objectId=c36a301213bb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c36a301213bb, replyNumber=0, likeNumber=73, createdTime=2022-04-28, rootId=0, userName=zhaozhouchifen, userId=524d95, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c36a301213bb, moduleTitle=Int J Urol：临床T3b前列腺癌患者中，根治性前列腺切除术与体外放射治疗+雄激素剥夺治疗哪个好？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c36a301213bb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1818961, encodeId=9161181896118, content=<a href='/topic/show?id=6b4c98688cb' target=_blank style='color:#2F92EE;'>#雄激素剥夺#</a>, objectTitle=Lancet Oncol：大剂量放疗+长期雄激素剥夺治疗前列腺癌的10年随访结果, objectType=article, longId=724218, objectId=c68de2421877, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c68de2421877, replyNumber=0, likeNumber=0, createdTime=2022-04-21, rootId=0, userName=zhaozhouchifen, userId=524d95, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c68de2421877, moduleTitle=Lancet Oncol：大剂量放疗+长期雄激素剥夺治疗前列腺癌的10年随访结果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c68de2421877)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1818958, encodeId=09691818958ef, content=<a href='/topic/show?id=6b4c98688cb' target=_blank style='color:#2F92EE;'>#雄激素剥夺#</a>, objectTitle=JU：推迟生化复发性前列腺癌的雄激素剥夺治疗时机？, objectType=article, longId=216791, objectId=0810216e914d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0810216e914d, replyNumber=0, likeNumber=68, createdTime=2021-12-11, rootId=0, userName=zhaozhouchifen, userId=524d95, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0810216e914d, moduleTitle=JU：推迟生化复发性前列腺癌的雄激素剥夺治疗时机？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0810216e914d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1818959, encodeId=5b4f181895977, content=<a href='/topic/show?id=6b4c98688cb' target=_blank style='color:#2F92EE;'>#雄激素剥夺#</a>, objectTitle=NEJM：Darolutamide联合雄激素剥夺疗法-多西他赛治疗转移性激素敏感前列腺癌, objectType=article, longId=299122, objectId=f136299122b1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f136299122b1, replyNumber=0, likeNumber=75, createdTime=2022-06-19, rootId=0, userName=zhaozhouchifen, userId=524d95, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f136299122b1, moduleTitle=NEJM：Darolutamide联合雄激素剥夺疗法-多西他赛治疗转移性激素敏感前列腺癌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f136299122b1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1818956, encodeId=946a181895694, content=<a href='/topic/show?id=6b4c98688cb' target=_blank style='color:#2F92EE;'>#雄激素剥夺#</a>, objectTitle=Eur J Cancer：雄激素剥夺疗法联合放疗治疗中危前列腺癌的3期临床试验结果, objectType=article, longId=204317, objectId=89b720431e86, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=89b720431e86, replyNumber=0, likeNumber=63, createdTime=2021-10-10, rootId=0, userName=zhaozhouchifen, userId=524d95, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=89b720431e86, moduleTitle=Eur J Cancer：雄激素剥夺疗法联合放疗治疗中危前列腺癌的3期临床试验结果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=89b720431e86)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1818957, encodeId=20c8181895eec, content=<a href='/topic/show?id=6b4c98688cb' target=_blank style='color:#2F92EE;'>#雄激素剥夺#</a>, objectTitle=J Clin Oncol：放疗(RT)和雄激素剥夺疗法(ADT)联合或不联合多西他赛治疗非转移性的不良风险前列腺癌的疗效:一项前瞻性随机研究, objectType=article, longId=213679, objectId=ac592136e99d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ac592136e99d, replyNumber=0, likeNumber=73, createdTime=2022-01-06, rootId=0, userName=zhaozhouchifen, userId=524d95, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ac592136e99d, moduleTitle=J Clin Oncol：放疗(RT)和雄激素剥夺疗法(ADT)联合或不联合多西他赛治疗非转移性的不良风险前列腺癌的疗效:一项前瞻性随机研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ac592136e99d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1818955, encodeId=5e8818189558f, content=<a href='/topic/show?id=6b4c98688cb' target=_blank style='color:#2F92EE;'>#雄激素剥夺#</a>, objectTitle=注意！雄激素剥夺治疗可能导致前列腺癌患者老年痴呆, objectType=article, longId=200662, objectId=4341200662ab, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4341200662ab, replyNumber=0, likeNumber=61, createdTime=2021-05-07, rootId=0, userName=zhaozhouchifen, userId=524d95, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4341200662ab, moduleTitle=注意！雄激素剥夺治疗可能导致前列腺癌患者老年痴呆, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4341200662ab)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1818953, encodeId=fb25181895346, content=<a href='/topic/show?id=6b4c98688cb' target=_blank style='color:#2F92EE;'>#雄激素剥夺#</a>, objectTitle=AUA：恩杂鲁胺联合雄激素剥夺疗法可显着改善去势抵抗性前列腺癌, objectType=article, longId=165939, objectId=009f16593979, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=009f16593979, replyNumber=0, likeNumber=87, createdTime=2019-05-24, rootId=0, userName=zhaozhouchifen, userId=524d95, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=009f16593979, moduleTitle=AUA：恩杂鲁胺联合雄激素剥夺疗法可显着改善去势抵抗性前列腺癌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=009f16593979)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1818954, encodeId=8f3b18189546b, content=<a href='/topic/show?id=6b4c98688cb' target=_blank style='color:#2F92EE;'>#雄激素剥夺#</a>, objectTitle=Lancet oncol：短期雄激素剥夺疗法联合放疗作为前列腺癌术后的补救治疗, objectType=article, longId=181919, objectId=45bc1819193b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=45bc1819193b, replyNumber=0, likeNumber=63, createdTime=2020-01-06, rootId=0, userName=仁医06, userId=55683, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=45bc1819193b, moduleTitle=Lancet oncol：短期雄激素剥夺疗法联合放疗作为前列腺癌术后的补救治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=45bc1819193b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1818952, encodeId=f98d181895210, content=<a href='/topic/show?id=6b4c98688cb' target=_blank style='color:#2F92EE;'>#雄激素剥夺#</a>, objectTitle=III期临床试验证明恩杂鲁胺与雄激素剥夺疗法（ADT）联合使用明显改善转移性前列腺癌的存活率, objectType=article, longId=160414, objectId=ea1416041497, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ea1416041497, replyNumber=0, likeNumber=81, createdTime=2019-04-16, rootId=0, userName=zhaozhouchifen, userId=524d95, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ea1416041497, moduleTitle=III期临床试验证明恩杂鲁胺与雄激素剥夺疗法（ADT）联合使用明显改善转移性前列腺癌的存活率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ea1416041497)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1818949, encodeId=96bd1818949aa, content=<a href='/topic/show?id=6b4c98688cb' target=_blank style='color:#2F92EE;'>#雄激素剥夺#</a>, objectTitle=Nat Commun：雄激素剥夺通过CREB-EZH2-TSP1途径促进前列腺癌的神经内分泌分化和血管生成, objectType=article, longId=150806, objectId=f841150806d3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f841150806d3, replyNumber=0, likeNumber=69, createdTime=2019-02-05, rootId=0, userName=zhaozhouchifen, userId=524d95, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f841150806d3, moduleTitle=Nat Commun：雄激素剥夺通过CREB-EZH2-TSP1途径促进前列腺癌的神经内分泌分化和血管生成, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f841150806d3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1818950, encodeId=742b18189501f, content=<a href='/topic/show?id=6b4c98688cb' target=_blank style='color:#2F92EE;'>#雄激素剥夺#</a>, objectTitle=Pharmacotherapy：前列腺癌患者雄激素剥夺治疗相关的主要长期副作用有哪些？, objectType=article, longId=154369, objectId=4bff154369ef, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4bff154369ef, replyNumber=0, likeNumber=105, createdTime=2019-09-06, rootId=0, userName=zhaozhouchifen, userId=524d95, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4bff154369ef, moduleTitle=Pharmacotherapy：前列腺癌患者雄激素剥夺治疗相关的主要长期副作用有哪些？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4bff154369ef)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1818951, encodeId=fd23181895115, content=<a href='/topic/show?id=6b4c98688cb' target=_blank style='color:#2F92EE;'>#雄激素剥夺#</a>, objectTitle=darolutamide联合雄激素剥夺疗法在非转移性去势抵抗性前列腺癌中显著延长了PFS, objectType=article, longId=160341, objectId=61af160341ee, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=61af160341ee, replyNumber=0, likeNumber=73, createdTime=2019-07-24, rootId=0, userName=zhaozhouchifen, userId=524d95, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=61af160341ee, moduleTitle=darolutamide联合雄激素剥夺疗法在非转移性去势抵抗性前列腺癌中显著延长了PFS, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=61af160341ee)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1818946, encodeId=a4ee1818946b2, content=<a href='/topic/show?id=6b4c98688cb' target=_blank style='color:#2F92EE;'>#雄激素剥夺#</a>, objectTitle=Eur Urol：比较醋酸阿比特龙和多西他赛联合雄激素剥夺治疗在高风险和转移性未经激素治疗的前列腺癌中的作用：系统评价与荟萃分析。, objectType=article, longId=116259, objectId=4d8911625997, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4d8911625997, replyNumber=0, likeNumber=74, createdTime=2018-05-23, rootId=0, userName=zhaozhouchifen, userId=524d95, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4d8911625997, moduleTitle=Eur Urol：比较醋酸阿比特龙和多西他赛联合雄激素剥夺治疗在高风险和转移性未经激素治疗的前列腺癌中的作用：系统评价与荟萃分析。, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4d8911625997)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1818944, encodeId=accd18189447f, content=<a href='/topic/show?id=6b4c98688cb' target=_blank style='color:#2F92EE;'>#雄激素剥夺#</a>, objectTitle=Scand J Urol：他汀类药物使用与雄激素剥夺疗法治疗前列腺癌恶化的关系, objectType=article, longId=111557, objectId=5d7211155e1f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5d7211155e1f, replyNumber=0, likeNumber=71, createdTime=2017-10-25, rootId=0, userName=zhaozhouchifen, userId=524d95, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5d7211155e1f, moduleTitle=Scand J Urol：他汀类药物使用与雄激素剥夺疗法治疗前列腺癌恶化的关系, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5d7211155e1f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1818943, encodeId=ef911818943a4, content=<a href='/topic/show?id=6b4c98688cb' target=_blank style='color:#2F92EE;'>#雄激素剥夺#</a>, objectTitle=JCO：雄激素剥夺治疗(ADT)对于前列腺癌老年患者来说，没有增加AD风险，对痴呆症也没有任何有意义的风险！, objectType=article, longId=111019, objectId=f209111019fe, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f209111019fe, replyNumber=0, likeNumber=90, createdTime=2017-09-10, rootId=0, userName=zhaozhouchifen, userId=524d95, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f209111019fe, moduleTitle=JCO：雄激素剥夺治疗(ADT)对于前列腺癌老年患者来说，没有增加AD风险，对痴呆症也没有任何有意义的风险！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f209111019fe)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1818948, encodeId=f40418189484b, content=<a href='/topic/show?id=6b4c98688cb' target=_blank style='color:#2F92EE;'>#雄激素剥夺#</a>, objectTitle=JAMA：体外放疗+雄激素剥夺治疗+近距离治疗是Gleason评分9-10分前列腺癌患者更佳治疗方案, objectType=article, longId=131723, objectId=6b88131e239c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6b88131e239c, replyNumber=0, likeNumber=76, createdTime=2018-10-07, rootId=0, userName=zhaozhouchifen, userId=524d95, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6b88131e239c, moduleTitle=JAMA：体外放疗+雄激素剥夺治疗+近距离治疗是Gleason评分9-10分前列腺癌患者更佳治疗方案, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6b88131e239c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1818945, encodeId=604418189455c, content=<a href='/topic/show?id=6b4c98688cb' target=_blank style='color:#2F92EE;'>#雄激素剥夺#</a>, objectTitle=J Pain Symptom Manage.：雄激素剥夺疗法对前列腺癌患者疼痛知觉、生活质量及抑郁的影响。, objectType=article, longId=114474, objectId=4f351144e46b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4f351144e46b, replyNumber=0, likeNumber=70, createdTime=2018-04-19, rootId=0, userName=zhaozhouchifen, userId=524d95, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4f351144e46b, moduleTitle=J Pain Symptom Manage.：雄激素剥夺疗法对前列腺癌患者疼痛知觉、生活质量及抑郁的影响。, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4f351144e46b)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

雄激素剥夺

2020-05-29

梅斯管理员 (审核中...)

前往app查看评论内容

#动脉粥样硬化# #雄激素剥夺#

ATVB 北京大学徐涛/姚伟娟团队揭示雄激素剥夺治疗相关动脉粥样硬化进展的机制

2024-01-13发表于陕西省

zhaozhouchifen (审核中...)

前往app查看评论内容

#雄激素剥夺#

Eur Urol Oncol：雄激素剥夺疗法联合根治性局部治疗与单独的雄激素剥夺疗法治疗新诊断寡转移性前列腺癌的疗效比较

2022-12-12

zhaozhouchifen (审核中...)

前往app查看评论内容

#雄激素剥夺#

Int J Urol：临床T3b前列腺癌患者中，根治性前列腺切除术与体外放射治疗+雄激素剥夺治疗哪个好？

2022-04-28

zhaozhouchifen (审核中...)

前往app查看评论内容

#雄激素剥夺#

Lancet Oncol：大剂量放疗+长期雄激素剥夺治疗前列腺癌的10年随访结果

2022-04-21

zhaozhouchifen (审核中...)

前往app查看评论内容

#雄激素剥夺#

JU：推迟生化复发性前列腺癌的雄激素剥夺治疗时机？

2021-12-11

zhaozhouchifen (审核中...)

前往app查看评论内容

#雄激素剥夺#

NEJM：Darolutamide联合雄激素剥夺疗法-多西他赛治疗转移性激素敏感前列腺癌

2022-06-19

zhaozhouchifen (审核中...)

前往app查看评论内容

#雄激素剥夺#

Eur J Cancer：雄激素剥夺疗法联合放疗治疗中危前列腺癌的3期临床试验结果

2021-10-10

zhaozhouchifen (审核中...)

前往app查看评论内容

#雄激素剥夺#

J Clin Oncol：放疗(RT)和雄激素剥夺疗法(ADT)联合或不联合多西他赛治疗非转移性的不良风险前列腺癌的疗效:一项前瞻性随机研究

2022-01-06

zhaozhouchifen (审核中...)

前往app查看评论内容

#雄激素剥夺#

注意！雄激素剥夺治疗可能导致前列腺癌患者老年痴呆

2021-05-07

zhaozhouchifen (审核中...)

前往app查看评论内容

#雄激素剥夺#

AUA：恩杂鲁胺联合雄激素剥夺疗法可显着改善去势抵抗性前列腺癌

2019-05-24

仁医06 (审核中...)

前往app查看评论内容

#雄激素剥夺#

Lancet oncol：短期雄激素剥夺疗法联合放疗作为前列腺癌术后的补救治疗

2020-01-06

zhaozhouchifen (审核中...)

前往app查看评论内容

#雄激素剥夺#

III期临床试验证明恩杂鲁胺与雄激素剥夺疗法（ADT）联合使用明显改善转移性前列腺癌的存活率

2019-04-16

zhaozhouchifen (审核中...)

前往app查看评论内容

#雄激素剥夺#

Nat Commun：雄激素剥夺通过CREB-EZH2-TSP1途径促进前列腺癌的神经内分泌分化和血管生成

2019-02-05

zhaozhouchifen (审核中...)

前往app查看评论内容

#雄激素剥夺#

Pharmacotherapy：前列腺癌患者雄激素剥夺治疗相关的主要长期副作用有哪些？

2019-09-06

zhaozhouchifen (审核中...)

前往app查看评论内容

#雄激素剥夺#

darolutamide联合雄激素剥夺疗法在非转移性去势抵抗性前列腺癌中显著延长了PFS

2019-07-24

zhaozhouchifen (审核中...)

前往app查看评论内容

#雄激素剥夺#

Eur Urol：比较醋酸阿比特龙和多西他赛联合雄激素剥夺治疗在高风险和转移性未经激素治疗的前列腺癌中的作用：系统评价与荟萃分析。

2018-05-23

zhaozhouchifen (审核中...)

前往app查看评论内容

#雄激素剥夺#

Scand J Urol：他汀类药物使用与雄激素剥夺疗法治疗前列腺癌恶化的关系

2017-10-25

zhaozhouchifen (审核中...)

前往app查看评论内容

#雄激素剥夺#

JCO：雄激素剥夺治疗(ADT)对于前列腺癌老年患者来说，没有增加AD风险，对痴呆症也没有任何有意义的风险！

2017-09-10

zhaozhouchifen (审核中...)

前往app查看评论内容

#雄激素剥夺#

JAMA：体外放疗+雄激素剥夺治疗+近距离治疗是Gleason评分9-10分前列腺癌患者更佳治疗方案

2018-10-07

zhaozhouchifen (审核中...)

前往app查看评论内容

#雄激素剥夺#

J Pain Symptom Manage.：雄激素剥夺疗法对前列腺癌患者疼痛知觉、生活质量及抑郁的影响。

2018-04-19

科室
- - 订阅+
  - 更多科室
工具
服务